Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Oncorus, Inc. (ONCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.1900+0.1400 (+4.59%)
At close: 04:00PM EST
3.1900 0.00 (0.00%)
After hours: 05:59PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Oncorus to Present at the H.C. Wainwright BioConnect Virtual Conference

    CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in a fireside chat at the H.C. Wainwright BioConnect Conference. The fireside chat will be available for on-demand viewing beginning Monday, January 10, 2022 at 7:00am ET under the Investors & Media

  • Simply Wall St.

    One Oncorus, Inc. (NASDAQ:ONCR) insider upped their stake in the previous year

    Insiders were net buyers of Oncorus, Inc.'s ( NASDAQ:ONCR ) stock during the past year. That is, insiders bought more...

  • GlobeNewswire

    Oncorus to Present at Upcoming Investor Conferences

    CAMBRIDGE, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in two upcoming virtual investor conferences: 33rd Annual Piper Sandler Virtual Healthcare Conference: A corporate presentation will be available on-demand starting Monday, November 22nd at 10:00 a.m

Advertisement
Advertisement